SAT404 Achieving Both Target Testosterone And Target Estradiol Levels May Not Be Practical In All Trans Feminine Users Of Estradiol - Which To Prioritize?

Disclosure: D. Slack: None. N. Krishnamurthy: None. F. Contreras-Castro: None. J.D. Safer: None. For feminizing gender affirming hormone therapy (GAHT), the Endocrine Society and WPATH SOC 8 suggest targeting testosterone (T) levels below 50 ng/dL and estradiol (E2) levels in the range of 100-200 pg...

Descripción completa

Detalles Bibliográficos
Autores principales: Slack, Daniel, Krishnamurthy, Nithya, Contreras-Castro, Felix, Safer, Joshua David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554830/
http://dx.doi.org/10.1210/jendso/bvad114.2075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554830/
http://dx.doi.org/10.1210/jendso/bvad114.2075

Ejemplares similares